Positive impactResults

Up 64% in 6 months already; should you still buy Neogen Chemicals? Antique sees 23% upside potential - Check target

Mint 2 hrs ago·20 Oct 2026, 4:05 am

Neogen Chemicals has seen its shares surge nearly 64% over the last six months, driven by strong demand for its battery chemicals and a growing reputation for reliable, non-Chinese supply. This rally has made the stock expensive, prompting Antique Stock Broking to initiate coverage with a Buy rating and a target price of ₹3,050.

The brokerage's bullish view rests on the company's ability to secure new customer approvals and capitalize on the global shift towards supply chains that are less dependent on Chinese manufacturing. They expect the company to deliver robust earnings growth over the next few years.

For investors, the key is to weigh the stock's recent performance against its long-term growth story. Investors should monitor the company's ability to execute on new customer wins and maintain its supply chain advantage to see if the current valuation is justified.

Excerpt from Mint

Antique Stock Broking initiated coverage on Neogen Chemicals with a Buy rating and a ₹ 3,050 target price, citing growth potential from battery chemicals, customer approvals and non-Chinese supply-chain demand. It forecasts strong earnings growth through FY30. After strong returns in the last 6 months, domestic…
Read the original at Mint

Affected stocks

Bullish1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Neogen Chemicals (NEOGEN).
  • Category: Results.
  • AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Neogen Chemicals. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Mint.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.